tirzepatide weight loss trial vs semaglutide: A new battle in obesity treatment Zepbound (tirzepatide) superior to Wegovy

GLP-1s may interact with insulin, other diabetes medications, or drugs used to treat depression and digestive or kidney diseases

Reduced Food Obsession : Patients often experience reduced food cravings and obsessive thoughts about eating, allowing them to focus on other life aspects

The IRS treats prescribed drugs for a diagnosed disease as qualified medical expenses under Section 213(d), so GLP-1s can be eligible on paper but employer-funded HRAs, and to a lesser extent FSAs and HSAs, are governed by plan documents that can be narrower than IRS rules

Remember that timing is secondary to quality

GIP(3-30)NH 2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study